Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Davita Healthcare Partners Inc (DVA)

Davita Healthcare Partners Inc (DVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Davita Healthcare Partners Inc 2000 16TH STREET DENVER CO 80202 USA

www.davita.com Employees: 70,000 P: 720-631-2100

Description:

DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.

Key Statistics

Overview:

Market Capitalization, $K 13,234,800
Enterprise Value, $K 22,661,090
Shares Outstanding, K 82,000
Annual Sales, $ 12,140 M
Annual Net Income, $ 691,540 K
Last Quarter Sales, $ 3,264 M
Last Quarter Net Income, $ 214,690 K
EBIT, $ 2,686 M
EBITDA, $ 3,432 M
60-Month Beta 0.89
% of Insider Shareholders 2.00%
% of Institutional Shareholders 90.12%
Float, K 80,360
% Float 98.00%
Short Volume Ratio 0.80

Growth:

1-Year Return 65.49%
3-Year Return 65.90%
5-Year Return 124.89%
5-Year Revenue Growth 6.45%
5-Year Earnings Growth 137.25%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 2.59 on 10/29/24
Next Earnings Date N/A
Earnings Per Share ttm 9.43
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -9.12%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 09/09/13

DVA Ratios

Ratio
Price/Earnings ttm 16.65
Price/Earnings forward 16.21
Price/Earnings to Growth 0.89
Return-on-Equity % 88.18%
Return-on-Assets % 4.88%
Profit Margin % 5.70%
Debt/Equity 16.29
Price/Sales 1.06
Price/Cash Flow 9.37
Price/Book 22.00
Book Value/Share 7.15
Interest Coverage -1.81
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar